• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Correlation between plasma estradiol and estrone-3-glucuronide in urine during the monitoring of ovarian induction therapy.

作者信息

Catalan R, Castellanos J M, Palomino T, Senti M, Antolin M, Galard R M

机构信息

Servicio de Bioquimica Hospital General Valle Hebrón, Barcelona, Spain.

出版信息

Int J Fertil. 1989 Jul-Aug;34(4):271-5.

PMID:2570765
Abstract

An improved radioimmunoassay was developed to determine estrone-3-glucuronide in daily urine. Resulting levels were compared with those of estradiol in plasma of 10 healthy women and 14 undergoing ovulation induction therapy with human menopausal gonadotropin and human chorionic gonadotropin. A highly significant correlation between plasma estradiol and urinary estrone-3-glucuronide in normal (r = .9209; P less than .01) and stimulated (r = .9229; P less than .01) women was demonstrated. These results proved that the pattern of excretion of estrone-3-glucuronide perfectly reflected the changes in plasmatic estradiol levels when monitoring ovarian induction and that estrone-3-glucuronide determinations can provide clinically useful information in human induction therapy.

摘要

相似文献

1
Correlation between plasma estradiol and estrone-3-glucuronide in urine during the monitoring of ovarian induction therapy.
Int J Fertil. 1989 Jul-Aug;34(4):271-5.
2
Estrone 3-glucuronide chemiluminescence immunoassay (LIA) and 17beta estradiol radioimmunoassay (RIA) in the monitoring of superovulation for in vitro fertilization (IVF): correlation with follicular parameters and oocyte maturity.雌酮3-葡萄糖醛酸苷化学发光免疫分析(LIA)和17β-雌二醇放射免疫分析(RIA)在体外受精(IVF)超排卵监测中的应用:与卵泡参数及卵母细胞成熟度的相关性
Acta Eur Fertil. 1992 Mar-Apr;23(2):63-8.
3
Excretion of total estrogens and estrone-3-glucuronide during treatment with human menopausal gonadotropins.人绝经期促性腺激素治疗期间总雌激素和雌酮-3-葡萄糖醛酸苷的排泄情况。
Eur J Obstet Gynecol Reprod Biol. 1985 Jul;20(1):27-33. doi: 10.1016/0028-2243(85)90080-2.
4
Excretion of estrone-3-glucuronide in urine in spontaneous and induced ovulatory cycles.在自发排卵周期和诱导排卵周期中尿中雌酮-3-葡萄糖醛酸苷的排泄情况。
Int J Fertil. 1988 May-Jun;33(3):181-7.
5
Urinary estradiol-17-beta-glucuronide assay for gonadotropin therapy.
Obstet Gynecol. 1981 Aug;58(2):142-7.
6
Determination of ovarian function using first morning urine steroid assays.使用晨尿类固醇检测法测定卵巢功能。
Obstet Gynecol. 1981 Jul;58(1):5-9.
7
Proceedings: Plasma oestradiol and progesterone estimations in the monitoring of the induction of ovulation by human menopausal gonadotrophin and human chorionic gonadotrophin.会议论文:在监测人绝经期促性腺激素和人绒毛膜促性腺激素诱导排卵过程中血浆雌二醇和孕酮的测定
J Endocrinol. 1974 May;61(2):LXXXI-LXXXII.
8
Plasma estradiol window and urinary estriol glucuronide determinations for monitoring menotropin induction of ovulation.用于监测促性腺素诱导排卵的血浆雌二醇窗和尿雌三醇葡萄糖醛酸苷测定
Obstet Gynecol. 1979 Oct;54(4):442-7.
9
[Enzymatic determination of urinary estrone and estradiol: correlations with plasma estradiol in the menstrual cycle in women].[尿中雌酮和雌二醇的酶法测定:与女性月经周期中血浆雌二醇的相关性]
J Gynecol Obstet Biol Reprod (Paris). 1982;11(4):477-81.
10
Direct assay of urinary steroid glucuronides for monitoring the approach of ovulation.直接检测尿甾体葡萄糖醛酸苷以监测排卵进程。
Int J Fertil. 1984;29(3):189-93.

引用本文的文献

1
Doppler Ultrasound Assessment of Blood Flow Indices in Childbearing Age Women Across the Menstrual Cycle.育龄期女性月经周期中血流指数的多普勒超声评估
Medicina (Kaunas). 2025 Feb 24;61(3):389. doi: 10.3390/medicina61030389.
2
Self-Monitoring of Urinary Hormones in Combination with Telemedicine - a Timely Review and Opinion Piece in Medically Assisted Reproduction.自我监测尿液中的激素水平并结合远程医疗——医学辅助生殖中的及时综述和观点文章。
Reprod Sci. 2022 Nov;29(11):3147-3160. doi: 10.1007/s43032-021-00754-5. Epub 2021 Nov 15.